The list of eligible groups has been amended to expand the implementation of additional doses to all fully vaccinated adults aged 18 years and above. All vaccination sites are reminded to prioritize the allocation and provision of doses for completion of primary series, and then those most at-risk populations for severe disease and deaths for booster / additional doses (English).